0.00
—
Close of 30 Oct 2026, in USD
About Fusion Pharm
Its shares trade under the ticker FSPM. It has been listed since 17 July 2001. In the fiscal year to 31 December 2012, it reported revenue of $808,400 and net income of $265,200. At that date it held total assets of $591,100 and shareholders' equity of $153,200.
Fusion Pharm, Inc. engages in the development and integration of a line of cultivation containers. The company is headquartered in Commerce City, Colorado. The company went IPO on 2001-07-17. The firm develops and integrates its PharmPod line of cultivation containers. The firm is a creator and manufacturer of these cultivation container systems. The firm offers PharmPlex farming solutions. The firm's PharmPods are used to cultivate a range of plants for businesses, universities and individuals. The firm's Pharmplex cultivation centers allow growing and harvesting vegetables and fruits, and distributing them. Its Pharmplex cultivation centers deliver produce within 100 miles from where they are grown.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Consumer Staples
- Industry
- Food Products
- Listed since
- 17 Jul 2001
- Employees
- 2
- Website
- fusionpharminc.com ↗
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Fusion Pharm Inc has several strengths that contribute to its success. One of the key strengths is its advanced technology and expertise in the pharmaceutical industry. The company has a strong portfolio of patented products and innovative solutions, allowing it to stay ahead of its competitors.
- Additionally, Fusion Pharm Inc has a robust distribution network, enabling efficient and widespread access to its products. The company also benefits from a strong customer base and loyal partnerships, which further enhances its market presence and revenue generation.
Weaknesses
- Despite its strengths, Fusion Pharm Inc also has some weaknesses that may hinder its growth. One major weakness is the company's limited financial resources. This restricts its ability to invest in research and development, expansion plans, and marketing initiatives.
- Furthermore, the company heavily relies on a few key suppliers, making it vulnerable to supply chain disruptions and fluctuations in raw material prices. In addition, Fusion Pharm Inc may face challenges in maintaining regulatory compliance, especially in a highly regulated industry like pharmaceuticals.
Opportunities
- Fusion Pharm Inc can leverage several opportunities to further its growth and profitability. One significant opportunity is the increasing global demand for pharmaceutical products. The company can explore new markets and expand its customer base, both domestically and internationally.
- Additionally, the rising focus on research and development in the healthcare sector provides an opportunity for Fusion Pharm Inc to develop and introduce innovative products and solutions. Furthermore, strategic partnerships and collaborations with other industry players can open doors to new opportunities and synergies.
Threats
- Fusion Pharm Inc faces various threats that could impact its performance. One major threat is intense competition within the pharmaceutical industry. The company needs to continuously innovate and differentiate itself to stay ahead in the market and retain its customer base.
- Moreover, changes in government regulations and policies, especially related to healthcare and drug approvals, pose a threat to Fusion Pharm Inc. The company must stay updated and compliant with these regulations to avoid legal and operational challenges.
- Additionally, economic uncertainties and fluctuations in currency exchange rates can impact the company's financial stability, as well as the pricing of its products in different markets.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.